In vitro and in vivo activities of anti-influenza virus compound T-705

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 4, 2002, Pages 977-981

  Furuta, Y ^a   Takahashi, K ^a   Fukuda, Y ^a   Kuno, M ^a   Kamiyama, T ^a   Kozaki, K ^a   Nomura, N ^a   Egawa, H ^a   Minami, S ^a   Watanabe, Y ^a   Narita, H ^a   Shiraki, K ^a  

^a TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 6 FLUORO 3 HYDROXY 2 PYRAZINECARBOXAMIDE; AMANTADINE; ANTIVIRUS AGENT; RIBAVIRIN; SIALIDASE INHIBITOR; T 705; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; DRUG STRUCTURE; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS RESISTANCE;

AMIDES; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INFLUENZA, HUMAN; LUNG; MALE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; ORTHOMYXOVIRIDAE; PYRAZINES; VIRUSES;

EID: 0036211719     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.4.977-981.2002     Document Type: Article

References (30)

1. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
2. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection
3. Clinical review of ribavirin
4. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate
5. Enhancement of rhinovirus plaque formation in human heteroploid cell cultures by magnesium and calcium
6. Serious morbidity and mortality associated with influenza epidemics
7. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA
8. Primary respiratory syncytial virus infection in mice
9. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections
10. Plaque inhibition assay for drug susceptibility testing of influenza viruses
11. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families
12. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine
13. Inhibition of human adenoviruses by 1-(2′-hydroxy-5′-methoxybenzylidene)amino-3-hydroxyguanidine tosylate
14. Rational design of potent sialidase-based inhibitors of influenza virus replication
15. Structure-activity relationship studies of novel carbocyciic influenza neuraminidase inhibitors
16. Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice
17. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: A comparison with ribavirin and demonstration of antiviral additivity with alpha interferon
18. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection
19. Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial
20. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza
21. Influenza virus M2 protein has ion channel activity
22. Evaluation of a tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
23. Broad-spectrum antiviral activity of virazole: 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
24. Mechanism of action of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole), a new broad-spectrum antiviral agent
25. Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071
26. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza
27. Ribavirin aerosol approved for severe cases of RSV in infants and young children
28. Ion channel activity of influenza A virus M2 protein: Characterization of the amantadine block
29. Design, synthesis, and broad spectrum antiviral activity of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides
30. Prophylactic treatment of cytomegalovirus infection with traditional herbs